Future of Medicine

Viking Therapeutics is a leading company in biotechnological innovation, focusing on metabolic and endocrine disorders. The compound VK2809 is currently in advanced clinical trials for the treatment of dyslipidaemia and NAFLD, showing significant potential for far-reaching impacts on health. The use of